|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,744,650 |
|
|
Indirect Value
|
$340,184,906 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,929,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2024-03-15 |
4 |
OE |
$12.46 |
$3,874,188 |
I/I |
310,930 |
1,439,466 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
|
2021-03-15 |
4 |
D |
$19.15 |
$183,687 |
I/I |
(9,592) |
1,440,369 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
68,303 |
1,449,961 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2023-03-17 |
4 |
D |
$36.29 |
$255,917 |
I/I |
(7,052) |
1,455,602 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2023-03-16 |
4 |
D |
$37.60 |
$375,925 |
I/I |
(9,998) |
1,462,654 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
56,892 |
1,488,371 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-17 |
4 |
D |
$34.18 |
$241,037 |
I/I |
(7,052) |
1,498,519 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-16 |
4 |
D |
$34.22 |
$356,778 |
I/I |
(10,426) |
1,505,571 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-15 |
4 |
D |
$34.74 |
$166,266 |
I/I |
(4,786) |
1,515,997 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
32,412 |
1,520,783 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Sci. and Chairman |
|
2023-03-15 |
4 |
D |
$36.84 |
$103,263 |
I/I |
(2,803) |
1,530,017 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
OE |
$12.02 |
$2,242,831 |
I/I |
186,545 |
1,532,674 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2023-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
34,301 |
1,532,820 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-05-23 |
4 |
OE |
$11.51 |
$4,400,447 |
D/D |
382,448 |
1,554,950 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-09-13 |
4 |
D |
$15.86 |
$2,440,569 |
D/D |
(153,882) |
1,578,055 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
OE |
$15.84 |
$3,559,834 |
I/I |
224,737 |
1,591,443 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist/Chairman |
|
2017-12-15 |
4 |
OE |
$12.02 |
$4,485,673 |
I/I |
373,091 |
1,636,469 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-09-13 |
4 |
OE |
$11.53 |
$2,040,660 |
D/D |
176,987 |
1,731,937 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-11-13 |
4 |
OE |
$12.02 |
$3,844,859 |
D/D |
319,792 |
1,897,847 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist/Chairman |
|
2017-12-15 |
4 |
D |
$19.30 |
$10,118,334 |
D/D |
(524,266) |
2,013,165 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2018-03-26 |
4 |
D |
$18.61 |
$385,748 |
D/D |
(20,728) |
2,040,619 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-17 |
4 |
D |
$19.91 |
$606,996 |
D/D |
(30,487) |
2,061,347 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-05-15 |
4 |
B |
$16.08 |
$401,970 |
D/D |
25,000 |
2,065,619 |
3.23 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-12-14 |
4 |
S |
$20.48 |
$892,309 |
D/D |
(43,577) |
2,072,317 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2023-03-17 |
4 |
D |
$36.29 |
$572,221 |
D/D |
(15,768) |
2,078,718 |
0 |
- |
|
170 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|